In light of our findings, expression of WT p53 may stimulate IL-6 induction that promotes cancer cell fitness and tolerance to genotoxic anticancer agents, thereby hampering the effectiveness of those anticancer therapeutics. This evidence concerns the gene TP53 and cancer.